Discovery of novel non-steroidal reverse indole mineralocorticoid receptor antagonists

被引：10

作者：

Ogawa, Anthony K. ^{[1
]}

Bunte, Ellen Vande ^{[1
]}

Mal, Rudrajit ^{[1
]}

Lan, Ping ^{[1
]}

Sun, Zhongxiang ^{[1
]}

Crespo, Alejandro ^{[2
]}

Wiltsie, Judyann ^{[1
]}

Clemas, Joseph ^{[1
]}

Gibson, Jack ^{[1
]}

Contino, Lisa ^{[1
]}

Lisnock, JeanMarie ^{[1
]}

Zhou, Gaochao ^{[1
]}

Garcia-Calvo, Margarita ^{[1
]}

Jochnowitz, Nina ^{[1
]}

Ma, Xiuying ^{[1
]}

Pan, Yi ^{[1
]}

Brown, Patricia ^{[1
]}

Zamlynny, Beata ^{[1
]}

Bateman, Thomas ^{[1
]}

Leung, Dennis ^{[2
]}

Xu, Ling ^{[2
]}

Tong, Xinchun ^{[2
]}

Liu, Kun ^{[1
]}

Crook, Martin ^{[1
]}

Sinclair, Peter ^{[1
]}

机构：

[1] Merck & Co Inc, Early Dev & Discovery Sci, 2000 Galloping Hill Rd, Kenilworth, NJ 07033 USA

[2] Merck & Co Inc, Early Dev & Discovery Sci, 126 E Lincoln Ave, Rahway, NJ 07065 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2016年 / 26卷 / 12期

关键词：

Mineralocorticoid receptor antagonist; Hypertension; Spironolactone; Eplerenone; MILD PATIENTS HOSPITALIZATION; ALDOSTERONE; EPLERENONE; POTENT; IDENTIFICATION; HYPERKALEMIA; SURVIVAL;

D O I：

10.1016/j.bmcl.2016.04.052

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Reported herein are a series of reverse indoles that represent novel non-steroidal mineralocorticoid receptor (MR) antagonists. The key structure-activity relationships (SAR) are presented below. This reverse indole series is exemplified by a compound that demonstrated efficacy in an acute natriuresis rodent model comparable to marketed MR antagonists, spironolactone and eplerenone. (C) 2016 Elsevier Ltd. All rights reserved.

引用

页码：2866 / 2869

页数：4

共 50 条

[1] Non-steroidal mineralocorticoid receptor antagonists
Meyers, Marvin J.
Hu, Xiao
[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (01) : 17 - 23
[2] Novel non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
Kintscher, Ulrich
Bakris, George L.
Kolkhof, Peter
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (13) : 3220 - 3234
[3] Discovery of potent, selective, non-steroidal mineralocorticoid receptor antagonists.
Neel, DA
Brown, ML
Lander, PA
Grese, TA
Defauw, JM
Doti, RA
Fields, T
Smith, S
Wiest, SA
Zimmerman, KM
Steinberg, MI
Jadhav, PK
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U46 - U46
[4] Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
Agarwal, Rajiv
Kolkhof, Peter
Bakris, George
Bauersachs, Johann
Haller, Hermann
Wada, Takashi
Zannad, Faiez
[J]. EUROPEAN HEART JOURNAL, 2021, 42 (02) : 152 - 161
[5] Non-steroidal mineralocorticoid receptor antagonists in heart failure
Filippatos, Gerasimos
Farmakis, Dimitrios
[J]. NATURE REVIEWS CARDIOLOGY, 2023,
[6] Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
Pandey, Arjun K.
Bhatt, Deepak L.
Cosentino, Francesco
Marx, Nikolaus
Rotstein, Ori
Pitt, Bertram
Pandey, Ambirash
Butler, Javed
Verma, Subodh
[J]. EUROPEAN HEART JOURNAL, 2022, 43 (31) : 2931 - 2945
[7] Non-steroidal mineralocorticoid receptor antagonists in heart failure
Filippatos, Gerasimos
Farmakis, Dimitrios
[J]. NATURE REVIEWS CARDIOLOGY, 2023, 20 (10) : 645 - 646
[8] Discovery of orally bioavailable, non-steroidal mineralocorticoid receptor antagonists: A tale of three platforms
Jadhav, P. K.
Matthews, Donald P.
Green, Jonathan
Fales, Kevin
Gavardinas, Kostas
Gernert, Douglas
Bell, Michael G.
Neel, David A.
Lander, Peter S.
Grese, Timothy A.
Borel, Anthony G.
Zhang, Chen
Kelley, Sally
Zimmermann, Karen
Steinberg, Mitchell I.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
[9] Discovery of novel indole derived mineralocorticoid receptor antagonists
Ogawa, Anthony
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
[10] Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
Savarese, Gianluigi
Lindberg, Felix
Filippatos, Gerasimos
Butler, Javed
Anker, Stefan D.
[J]. DIABETOLOGIA, 2024, 67 (02) : 246 - 262

← 1 2 3 4 5 →